8 transactions in one company, from February 6, 2026 to August 17, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | RXRX | 8 | — | $179K |
8 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Aug 17 | F | 80,498 | $3.16 | $254K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Jun 5 | SPLAN | 23,588 | $3.58 | $84K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | May 15 | F | 62,701 | $3.04 | $191K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Mar 9 | SPLAN | 28,298 | $3.35 | $95K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Feb 17 | F | 14,280 | $3.49 | $50K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Feb 6 | F | 10,364 | $3.98 | $41K |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Feb 6 | A | 30,346 | $0.00 | — |
| RECURSION PHARMACEUTICALS, INC. | RXRX | Najat KhanCEO | Feb 6 | A | 1,673,546 | $0.00 | — |